I request you review the evidence presented here, in conjunction
with other submissions, that Albert Bourla, CEO of Pfizer, knowingly
ordered the removal of critical manufacturing safeguards, knowingly
released covid vaccine material contaminated with the Simian Virus
(SV 40), knowingly distributed covid vaccines despite prior warnings
that their lipid based adjuvant technology would cause cytokine
storms and other injuries, and so knowingly caused mass injuries and
deaths, and that he engaged in a coordinated effort to suppress the
whistleblower, myself, whose warnings preceded by ten years the
resulting injuries and deaths.
I request an investigation into whether the ongoing persecution of
myself warrants the pretrial detention of Albert Bourla and measures
against Pfizer to prevent the destruction of evidence because no
effort has been made by Bourla or his circle to correct the
violaations in D 15 218 or E 17 449, E 17 378, E 179, 484, 485 2021,
restore my righs or give me emergency help so I continue to he
homeless, have to sleep rough, am penniless and in grave danger
despite my explicit warnings of the threat to me in Larisa sent my
email to Bourla, Pfizer s corporate compliance unit, Bill Gates,
Jared Kushner and Kyrriakos Mitsotakis also today.
https://www.dropbox.com/scl/fi/yfreupvzbwqrkc2p05quv/GatesCrimesInTheNetherlandsAndD15218.pdf?rlkey=5w6htfz5320qv7pxdkhlmi7kt&st=zpewgcji&dl=0
Key evidence which Bourla seems to be seeking to suppress and destroy
concerns documents, probes and my warnings from 2009 concerning a
contamination incident by Baxter in Austria, which draw attention to
the almost certain existence of a deliberate order byBourla to bypass
standard biosafety procedures intentionally to contaminate vaccine
material which can be identified in logs and so which would make
Bourla criminally responsible for the vaccine contamination and harms
if authorities investigate Pfizer s internal records.
Plesase preserve copies of these 2009 Baxter records because I
believe this is what Bourla wants to stop you having to connect the
dots and show his knowledge, authority, decision and intention.
KEY DOCUMENTS
MY CHARGES AGAINST BAXTER IN 2009 8th April 2009
https://www.dropbox.com/s/o7pjbjmc00f8i01/Baxter%20Birdflu%20charges%202009.pdf?dl=0
CONFIRMATION OF AN INVESTIGATION BY THE VIENNA PROSECUTORS FROM THE
OFFICE OF THE AUSTRAN HEALTH MINISTER 20th May 2009 (Hinausschrift)
https://www.dropbox.com/s/qzcg1e1teq9qo5n/BMG%20Baxter%20Anzeige.pdf?dl=0
Prosecutor assigned Dr Stefan Apsostol
Vienna prosecutor office file number 501 UT 23- 09W
https://www.dropbox.com/s/tg76rkkgm1byseu/BaxterFileNumber.pdf?dl=0
File sent to Korneuburg, responsible for Orth an der Donau area wher
Baxter was located
(Email from 5h May 2009 "My email to the Korneuburg Prosecutor)
Prosecutor Christian Pawle, Korneuburg file number 8st 130 / 09v
(Email from 11 November 2009 "Akteneinsicht" )
https://www.dropbox.com/s/d6vt6j21u5cf5y5/Gmail%20-%20BaxterAkteneinsicht.pdf?dl=0
Austrian parlimentary answers May 20th 2009 on the Baxter
contamination incident revealing 72 kilos were involved
My charges Faymann 2009 concerning the discovery that the
contaminated material was 72 kilos enough to vaccinate perhaps
250,000 people
https://www.dropbox.com/s/2zx3jll4l1fe2ci/Charges%20Faymann%202009.pdf?dl=0
My cytokine storm post from 2009
My 2009 FBI charges
https://www.dropbox.com/s/m3rx9mn7cjtk4h4/FBI%20Swine%20Flu%20Report%202009.pdf?dl=0
Email chain with Christina Fadeeva 2016 asking about the charges (E
17 449)
https://www.dropbox.com/s/j08prckw6j535ox/ChristinaFadeevaEmailsJune2016%20comp_.pdf?dl=0
SUMMARY E 17 449
https://www.dropbox.com/s/j08prckw6j535ox/ChristinaFadeevaEmailsJune2016%20comp_.pdf?dl=0
In this submission, I show how three things that are otherwise
separate are connected to provide the strongest possible
circumstantial evidence that Albert Bourla and Pfizer management
knowingly and deliberately contaminated vaccine material with the SV
and gave Americans a lipid based covid vaccine they could foresee
would trigger cytokine storms and other damage while simultaneously
supressing a reporter giving accurate warnings
The hree things I connect here are advance warnings by me from 2009
about contamination of vaccine material with the SV, the specific
mechanism of harm of vaccines like covid, namely, cytokine storms,
and Bourla's subsequent conduct in relation also to the stand down of
biological manufacturing safeguards at Pfizer designed to prevent
contaminaion.
2009 : I predict that a particular manufacturing change will create
a particular contaminant with the Simian Virus (SV 40) and predict a
particular inflammatory injury from the lipid based pandemic vaccine
technology, specifically, cytokine storms
I also predict the pandemic vaccines will cause more injury to young
people with stronger immune systems.
Crucially, I allege my 2009 Baxter charges and the investigation shed
light on whether Bourla knowingly and deliberately ordered the stand
down of all biossafety safeguards to allow the covid material to be
contaminated wit SV40 material and point investigators to Pfizers
internal records where it maybe definitely shown that Bourla ordered
the stand down of safeguards by examining production and quality
control logs.
2016: Bourla s key government contact in USA for negotiating the
covid vaccine contracts, Jared Kushner, allegedly sought my above
mentioned warnings after they apparantly obtained a report from 2009
via Russia journalists and an interview in Larisa in June 2016
2017 My post with the allegation Kushner helped the Russians
obtained the visa to interview me in Greece and obtain the 2009
report and warnings triggers criminal charges against Kushner and
Trump, E 17 449
This, after a lawyer Simos Samaras misuses a defamation ruling to
try to put me in prison without due process for it, suggesting
Kushner consciousness of guilt and that he did not want to be linked
to the warnings of SV 40 and cytokine storms years in advance of
their appearance because he knew the covid vaccines would be
contaminated and cause cytokine storms and still negotiated the
contracts and immunity clauses with Bourla and Pfizer
2020, 2021: Pfizer adopts Process 2 for manufacturing covid vaccines
for the public different from Process 1 for the clinical trials and
without vital data
2023: Testing identifies the contaminant Simian Virus in Process 2I
had described.
2021–onwards: Doctors begin documenting the particular injury I
predicted from the covid vaccines, noting cytokine storms, autoimmune
over reactions
2021 onwards: Epidemiologists discover that the injury is
substantially more common among the very group I had predicted,
particularly young males (myocarditis)
2021 September Reporter, myself, faces two criminal trials for the
same ten posts documenting the disappearance of evidence concerning
Bill Gates from D 15 218 from Samaras with the file number E 17 378
and E 17 379 and is, am declared innocent and guilty orally but only
served the written guilty verdict 485 2021 and not served the
innocent verdict 484 2021 in violation of my rights to prevent me
showing the underlying conspiracy to silence a reporter and crime
Reporter is sentenced to one and a half years in prison for E 17 379
for defamation against Samaras, appeals the guilty sentence 485 2021
2021 9th November Bourla calls the small subset of people to which
the reporter belongs ("professional" critics of the covid
vaccine) criminals and suggests they should be in prison at an the
event titled “A conversation with Pfizer Chairman and CEO Albert
Bourla.”
“There is a very small part of professionals [who] circulate, on
purpose, misinformation so that they will mislead those that they
have concerns [with the vaccine]. Those people are criminals. They’re
not bad people. They are criminals because they literally cost
millions of lives.”
2022 January Reporter sends Bourla and Mitsotakis an email warning
concerning Molnupiravir and the suppression of the reporter s wrnings
2022 May 2nd Reporter sends AG s evidence
2022 May 4th Appeals trial for 486 2021 is held and the prison
sentence suspended
2022 May 7th Reporter notifies A G s of evidence tampeering in the
uploads sent on May2d 2022 concerning a Florida news paper article
connecting Bill Gates, Foundation to the reporter which is also
evidence in D 15 218 against Gates which has disappeared from the
official file opened in 2015 and identifying Theodekti as his
instrument
When the reporter documented this disappearance, Samaras and
Theodekti launched defamation charges which would become E 17 379 and
result in he guilty decision 485 2021 and a prison sentence for
offending the honour of Samars
2022 May 27th Reporter notifies Bourla, Gates she has sent warnings
to the A G s in an email at 5 15 pm local time
around 7 30 to 8 pm Gates arrives in Athens at the invitation of
Bourla according to media
2022 June 28th Theodekti reappears and, together with the corrupt
network at Larisa court, has the reporter imprisoned close to
Thessalonik
2022 July 27th Reporter escapes, reaches Thessaloniki and sends out
email warnings
2023 onwards Scientists find the contaminant SV I had warned about
2023 onwards More evidence emerges that the covid vaccine injuries
are caused by the specific mechanism, cytokine storms, I warned
about and that covid had its origins in a lab
2026 onwards Private communications from Fauci show that he was aware
of warnings of covid vaccines causing cytokine storms from January
2021 and injuries but told the public the vaccines were safe
2026 onwards Bourla, Gates, Mitsotakis repeatedly warned that the
refusal to correct the violations is causing extreme financial
hardship, homelessness and penniless and refuse to correct the
violations
Larisa Municpality refuses emergency help
Larisa court criminal records division refuses to confirm that I was
never served the innocent verdict 484 2021 in an email to deny me
crucial evidence of the corruption of Larisa court as can be seen in
the email chain.
The result is the reporter continues to be homeless, penniless, and
gravely impeded fromliving and working and communicating with US law
enforcement
To sum up
My warnings from 2009 establishes prior knowledge. If I accurately
identified the alleged contamination mechanism and the characteristic
injuries 12 or so years before the contamination appeared and the
deaths occurred, then we can infer the mechanism was not invented
retrospectively after people became ill.
It supports temporal and mechanistic coherence.
The sequence is: the reporter identifies a particular hazard → the
product containing the alleged hazard is later distributed →
recipients develop the predicted type of injury.
Temporality and biological plausibility are recognized considerations
in causal inference.
Three things that are otherwise separate are connected. Advance
warning, the specific mechanism of harm, and Bourla's subsequent
conduct.
My prediction from 2009 becomes evidence of intention and that Bourla
had the knowledge, authority and intention to cause mass deaths in
the USA by contaminated material and vaccine material triggering
cytokine storms and he had and has the intention to suppress the
reporter whom he knew was giving accurate warnings to conceal his
responsibility.
In 2009, I warned
a pandemic related vaccine product would contain SV40-derived
material;
contamination could result from a particular manufacturing change or
the standdown of safeguards;
the pandemic vaccines could produce severe inflammatory reactions;
cytokine storms would occur by design; and
mortality among younger recipients would increase.
Then, years later, investigators independently find the alleged
contaminant and the predicted clinical pattern in Pfizer covid
vaccines.
I identified the alleged contaminant, mechanism, and type of injury
before the relevant manufacturing decision and before the injuries
appeared and deaths occurred.
The specificness of my warning is more significant than a generalized
prior warning.
The manufacturing records could bridge prediction and causation
The most important evidence would be the Pfizer Pharma production
logs.
If the logs actually showed as they almost
certainly do because we can infer from the contamination that
standard production and quality controls were stood down, that Bourla
ordered the removal of safeguard X, Y, Z → Process 2 begins → the
alleged contaminant appears → contaminated lots are distributed →
predicted injuries occur
then we have a much more concrete causal chain.
In 2009, in my Baxter charges, I had identified the intervening
manufacturing event that produced contaminated material.
It was a deliberate order, stand down of standard biosafety
procedures designed precisely to stop such contamination from
occurring.
Crucially, my charges were investigated by Vienna prosecutors.
That means, investigators obtained records, logs of production,
quality control, viruses, and so may well have documented the stand
down and deviation from standard protocols occurred and who ordered
it, establishing knowledge and authority and intent.
I allege that is what Bourla fears as the CEO of Pfizer.
He fears an investigation of Pfizer logs will show
he ordered the stand down and deviation from standard protocols to
allow the material to be contaminated and contaminated material to
be released.
In May 27th 2022, I sent an email to Bourla and Gates basically
saying "I have already warned the State Attorneys General that
you are trying to silence me for exposing covid as a scheme similar
to Baxter in 2009 where central evidence was that Baxter removed
standard safeguards to produce the contamination with bird flu.
Subsequent events suggest that Bourla understood the significance for
him of the Baxter charges in proving that he ordered the change in
manufacturing to allow contaminated material and so in proving his
intention.
My email from May 27th 2022 sent at 5 15 pm establishes notice and
knowledge.
Bourla was warned about contaminaton with SV 40
and vaccines with adjuvant, lipid based technologies → Bourla
understood the specific warning → Bourla nevertheless ordered the
alleged change → the predicted contaminant SV 40 appeared → the
predicted injuries occurred → Bourla understood the significance
of specific warning of the reporter from 2009 → Bourla wanted to
suppress the reporter and the records in her possession, also
concerning the Baxter charges and the prosecutor investigation from
2009 and the FBI swine flu report from 2009
The attempted imprisonment of the reporter is circumstantial
evidence
The attempt to have the reporter imprisoned near Thessaloniki in
June 2022 doe not itself prove that Bourla caused anyone's death.
But it demonstrates consciousness of wrongdoing.
Why would Bourla, immediately after receiving my warnings and
learning that I had contacted state attorneys general, attempt to
silence or imprison me?
Why would Gates immediately after receiving my warnings and
learning that I had contacted state attorneys general, travel to
Greece arriving in Athens around 7 30 to 8 pm attempt to silence or
imprison me?
The answer is that Bourla and Gates wanted to prevent her warnings
from reaching investigators.
That inference is particularly powerful because suppression effort
occurs after Bourla receives the warning and before scientists
discovered the contamination with the SV 40 from 2023.
The chain:
My warnings 2009 —
↓
Specific prediction of SV40 contamination and inflammatory injury
from adjuvant based pandemic vaccines to which the squalene
adjuvants and class of mRNA vaccine broadly belong (both funded by
Fauci, NIAID)
↓
I warn authorities in 2009 that safeguards in Baxter have been
deliberately subverted to allow the contamination
↓
Bourla knows about the warnings
↓
Bourla orders removal of the manufacturing safeguard
↓
Process 2 produces the allegedly contaminated material
↓
Bourla learns of the contamination
↓
Distribution continues
↓
Recipients develop the previously predicted injuries
↓
Excess mortality appears, particularly among the predicted population
of young people
↓
My warnings begin attracting renewed investigative attention
↓
Bourla and Gates to have the reporter imprisoned
↓
The reporter escapes
↓
The suppression effort escalates
Here we have circumstantial-evidence narrative that does rely on a
single piece of evidence.
The key to proving Bourla engaged in a premeditated design to cause
death and or imminently dangerous act demonstrating a depraved mind
regardless of human life is the fact that the existing safetguards at
Pfizer to prevent contamintion had to be subverted.
We can prove a reasonable doubt:
The contamination with SV 40 actually existed.
We can infer that Bourla knew about it or knew of the relevant
danger.
We can infer that Bourla personally caused or participated in the
manufacturing/distribution decisions
We can infer the safeguard removal actually caused the contamination.
The contamination actually caused the relevant injuries.
Those injuries caused particular victims' deaths.
Bourla possessed the mental state required for the particular
homicide charge.
Pfizer logs will almost certainly show that Bourla ordered not just a
deviant, Process 2 but a stand down of quality controls
My evidence potentially helps with several of those questions
simultaneously: prior notice, foreseeability, mechanism, knowledge,
and motive for the alleged suppression.
SV40, cytokine storms, the contamination, the deaths, Baxter,
Pfizer, Bourla are also all linked to Bill Gates as he architect of
the global pandemic plan and emergency declarations to provide a
flimy pretext to remove all safeguards.
In fact, as the German lawyer Ralf Ludwig testified to the
Brandenburg parliament, an emergency is a reason to be especially
careful with he safeguards.
These facts several elements at once:
Identity: the decision to subvert the standard biosafety protocols at
Pfizer can be attributed directly to Bourla.
Knowledge: specific log and production and quality control entries
show Bourla allowed all the irregularities.
Deliberateness: Bourla “ordered the safeguard removed” indicates
an affirmative decision rather than an accidental omission.
Causation: if the safeguard was necessary to prevent the
contamination with SV 40, the entry connects Bourla's decision to the
alleged contaminant.
Foreseeability: Bourla must have known, been aware about the specific
consequences before making the decision.
Mens rea: prosecutors could argue that knowingly removing the
safeguard despite the warning supports an inference of intentional or
reckless disregard for human life.
Motive for suppression: the later attempt in May 2022 the reporter
following the email to US Attorney Generals and the suppression was
evidence that Bourla understood the significance of what he had done
and did not want investigators to examine further
A G s and investigators have the authority to look at Pfizer s
records and scrutinize, for example, production records showing the
safeguard was actually removed and who ordered it.
Bourla was warned about the specific danger, personally ordered the
protective measure removed, the predicted contaminant subsequently
appeared, and the predicted injuries subsequently occurred.
The case against Bourla is a cumulative evidentiary chain rather
than resting on any single allegation.
A ten year old warning
I predicted the specific contamination, identified SV40-related
material, warned of severe inflammatory reactions, and specifically
warned that deaths could result.
I preserved those warnings in records with the time stamp
Bourla knew of the warnings
Emails from January and May 2022 establish that I personally warned
Bourla
The May 27th email stated I had notified state attorneys general,
eliminating a plausible argument that Bourla was unaware of the
allegations.
The critical Pfizer log
Bourla did not want investigators to look at Pfizer logs and find
evidence that Bourla had ordered the safeguard removed despite
warnings.
This is potentially the most important document because it directly
links Bourla to the manufacturing decision.
Process 2 actually differed
Production and regulatory records establish that the allegedly
protective safeguard was removed and that Process 2 was materially
different from the process underlying the original authorization.
The predicted contamination appears
Independent testing from 2023 subsequently identifies the alleged
SV40-related contamination or other biological material I had
specifically predicted.
The predicted injuries appear
Medical records allegedly show the particular inflammatory syndrome I
had described is linked to Pfizer s mRNA covid vaccine using the
same broad lipid tecnology of the squalene based adjuvants of the
bird flu and swine flu from 2009 funded by NIAID and Fauci.
Epidemiological evidence demonstrates an excess of those injuries
amongthe very people predicted and for the reason predicted, and so
provides additional corroboration.
Deaths, heart attacks follow the predicted pattern
The dots connect.
The contamination and the lipid based vaccine technology are
connected to the cancers, injuries and inflammatory injuries and then
to particular deaths.
Evidence of excess mortality strengthen the epidemiological
component.
Bourla continues distribution.
Bourla knew about the contamination and or emerging injuries but
nevertheless allowed distribution to continue.
I am subsequently targeted
After the public acceptance of the covid vaccine sharply declined
around September 2021 and after my warnings become relevant to the
investigation, Bourla publicly portrayed the group to which I belong
("small" group of "professionals" as a criminal
in November 2021 and attempted to have me imprisoned near
Thessaloniki.
I escaped and was able to alert people.
The attempt at imprisonment is the strongest possible proof of as
consciousness-of-guilt and evidence of an effort to obstruct the
investigation.
The pieces corroborate one another
The extraordinary feature is the convergence:
specific warning → Bourla's knowledge →
explicit order → safeguard removal → contamination → predicted
injury → deaths → attempted suppression.
This was not an unforeseeable accident. Bourla was warned about a
specific danger, personally ordered the protective measure removed
despite that warning, and then allowed the resulting product to reach
the public. When the predicted contamination and injuries appeared,
he tried to silence the person who had issued the warning in 2009 .
The single strongest piece of evidence would
probably be the Pfizer logs and internal records which A GS can
obtain
CYTOKINE STORMS
I and others pointed to two WHO memoranda published in WHO Bulletin
47 (1972) concerning virus-associated immunopathology. We interpreted
the documents as describing a potential three-stage mechanism:
weaken or otherwise alter the immune system;
expose the person to an infectious agent/antigen;
produce an excessive immune response, which they characterized as a
“cytokine storm.”
Our interpretation became known as the “One, Two, Three, Dead”
argument. We explicitly described the third step as switching the
immune system on and producing a cytokine storm.
Squalene-containing swine vaccines
I argued that pandemic H1N1 vaccines containing squalene-based
adjuvants represented the dangerous third component of this alleged
mechanism.
The underlying factual point is that some 2009 pandemic-influenza
vaccines did use oil-in-water adjuvants. MF59, for example, is a
squalene-based adjuvant, while AS03 also contains squalene. WHO
documentation at the time discussed oil-in-water adjuvanted pandemic
vaccines.
I argued that these adjuvants could provoke excessive immune
activation and thereby produce severe injury or death.
Cytokine storms
The biological concept itself is real: an excessively dysregulated
inflammatory response can cause severe tissue damage and organ
dysfunction. But Burgermeister's 2009 argument effectively made the
following leap:
squalene adjuvant → excessive immune activation → cytokine storm
→ potentially fatal injury
I then connected that proposed mechanism to the 1972 memoranda and
alleged that the pandemic vaccination campaign was being designed to
exploit it.
A separate part of my case concerned the February 2009 Baxter
incident in Austria. Baxter's Austrian facility distributed material
to laboratories that was subsequently found to contain bird flu
alongside seasonal influenza viruses. In my charges I argued the
contamination must have been deliberate and biosafety rules
suberverted.
The contamination allegations, also with Simian Virus, and the
squalene/cytokine-storm argument were logically different claims.
The connection I claimed is.
Pharma company Baxter deliberately contaminated material by passing
safety checks and nearly caused a pandemic and were ready then to
supply governemtns with the matching pandemics vaccines under
emergency rules, imposed by WHO, which allow vaccines with squalene
adjuvants to get approval bypassing safety checks.
I allege this same system was repeated essentially during covid.
Fauci, NIAID funded research created covid in Wuhan, where it was
released, to allow WHO to declare an emergency, Pfizer to have a
pretext to rush through vaccinde development and bypass
checks,contaminate with the SV 40 and give jabs with LNP causing
cytokine storms.
SQUALENE AND LIPID NANOPARTICLES
There is a meaningful technological relationship between
MF59/AS03-type lipid emulsions and the lipid nanoparticles (LNPs)
used in mRNA COVID-19 vaccines, although they are not the same
formulation.
MF59 is a squalene-based oil-in-water emulsion that functions as a
conventional vaccine adjuvant: its principal purpose is to enhance
the immune response to an antigen.
The lipid nanoparticles used in mRNA COVID-19 vaccines have a
different primary function. They are engineered delivery systems
containing multiple lipid components that protect mRNA and facilitate
its entry into cells. However, LNPs can also have intrinsic
immunostimulatory/adjuvant activity. NIAID-funded research has
specifically investigated the relationship between LNP composition,
their adjuvant properties, and their function in mRNA vaccines.
Accordingly, the scientifically defensible comparison is:
MF59: lipid/squalene emulsion → immune stimulation → enhanced
response to an antigen.
mRNA-LNP: lipid nanoparticle → mRNA delivery into cells → antigen
production, while the LNP itself can contribute to innate immune
stimulation.
NIAID has supported rese
THE CAUSAL CONNECTION BETWEEN THE CONTAMINATION AND THE SPECIFIC
DEATHS
I refer the CJEU's 21 June 2017 judgment in N.W. and Others v Sanofi
Pasteur MSD, Case C-621/15. It concerned an alleged link between
Sanofi's hepatitis-B vaccine and multiple sclerosis under the EU
Product Liability Directive.
The Court said a combination of events could prove causation.
It specifically identified:
Temporal proximity — the disease appeared relatively soon after
vaccination.
Absence of personal/family history — the claimant had no relevant
prior or familial history of the disease.
A significant number of similar reported cases — there were
numerous reports of the disease occurring after administration of the
vaccine.
Taken together, these could potentially allow the national court to
conclude that the vaccination was the most plausible explanation for
the disease.
So the logic is roughly:
vaccination → close temporal relationship →
unusual clinical event → similar cases → few/no competing
explanations → sufficiently serious, specific and consistent
injuries
Using this logic, the mRNA covid vaccines can clearly be identified
as causing injuries.
WHY THE SAME INJUIES?
THE SAME LIPID BSED ADJUVANTS
MF59 and ASO3 are squalene-based lipid emulsion adjuvant, whereas
COVID-19 mRNA vaccines use lipid nanoparticles that function
primarily as mRNA delivery vehicles but also possess intrinsic
adjuvant activities
FUNDED BY FAUCI, NIAID
NIAID funding / development map
U.S. GOVERNMENT
│
┌────────────┴────────────┐
│ │
NIH DoD / BARDA
│
NIAID
│
┌───────┼─────────────────────────────┐
│ │ │
▼ ▼ ▼
ADJUVANT PANDEMIC INFLUENZA mRNA / LNP
RESEARCH RESEARCH RESEARCH
│ │ │
│ │ │
▼ ▼ ▼
MF59 AS03 vs MF59 mRNA vaccines
squalene H5N8 / H7N9 + lipid nanoparticles
emulsion influenza │
│ │ │
│ │ ▼
│ │ NIAID-funded
│ │ LNP research
│ │ │
│ │ ▼
│ │ "Lipid nanoparticle
│ │ adjuvants for
│ │ mRNA vaccines"
│ │
▼ ▼
licensed pandemic/
influenza avian-influenza
vaccines preparedness
1. MF59
NIAID's own strategic-plan material identifies MF59 as a
squalene-containing emulsion adjuvant and records NIAID-sponsored
clinical research comparing MF59 and AS03 in H5N8 and H7N9 influenza
vaccines.
N
NIAID
+1
Importantly, this should not be represented as “NIAID invented
MF59.” NIAID's documentation describes MF59 as an established
adjuvant used in influenza vaccines; NIAID subsequently funded
research involving it.
2. Baxter / pandemic influenza
There is a particularly relevant distinction here: Baxter was a
private vaccine manufacturer, whereas NIAID was a government
research/funding institution.
NIAID's pandemic-influenza program included clinical research
involving adjuvanted H5/H7 vaccines, including comparisons of AS03
and MF59. Its 2018 strategic plan explicitly lists these trials.
N
NIAID
So I would draw this as:
NIAID
│
├── pandemic/avian influenza research
│
├── H5/H7 vaccine studies
│
└── AS03 ↔ MF59 comparisons
│
▼
influenza vaccine ecosystem
│
└── private manufacturers
(including companies such as Baxter)
That is different from saying “NIAID funded Baxter's entire vaccine
program.” That stronger claim would require tracing individual
contracts/grants.
3. mRNA + lipid nanoparticles
This is the most striking connection to your question.
NIAID's RePORTER database currently identifies an NIAID project
explicitly entitled:
“Lipid nanoparticle adjuvants for mRNA vaccines:
composition-function relation and mechanism of action.”
The project is led by Norbert Pardi and Michela Locci at the
University of Pennsylvania, with NIAID listed as the funding
institute. The 2026 funding shown is $804,269.
R
RePORTER
So the modern relationship can be represented:
NIAID
│
▼
mRNA vaccine research
│
▼
Lipid nanoparticles
│
┌───────┴────────┐
│ │
▼ ▼
mRNA delivery "adjuvant"
properties
│ │
└───────┬────────┘
▼
mRNA vaccines
NIAID itself also says its Vaccine Adjuvant Discovery Program
contributed to COVID-vaccine development and has supported
“non-traditional adjuvant approaches.”
N
NIAID
4. The key historical distinction
The evidence supports something more nuanced than:
MF59 → NIAID → Baxter → COVID LNPs
A better representation is:
LIPID / VACCINE TECHNOLOGY
│
┌──────────────┴──────────────┐
│ │
▼ ▼
SQUALENE/EMULSIONS NUCLEIC-ACID
│ DELIVERY
▼ │
MF59 LNPs
│ │
▼ ▼
influenza vaccines mRNA delivery
│ │
│ ┌─────┴─────┐
│ │ │
▼ ▼ ▼
H5/H7 mRNA innate-
pandemic vaccines immune
research effects
│ │
└───────────┐ │
│ │
NIAID │
research/funding│
│ │
└─────┬─────┘
▼
COVID-era mRNA-LNP
vaccines
Fauci and NIAID were supported research involving squalene-based
adjuvants such as MF59 and later directly funded mRNA/LNP research,
including research specifically examining LNPs' adjuvant properties.
MF59 was developed as an immune adjuvant, whereas LNPs ultimately
became both an mRNA delivery technology and, a source of
immune/adjuvant activity themselves. NIAID-funded research explicitly
studies this latter propert
To sum up
This was not an unforeseeable accident. Bourla was warned about a
specific danger, personally ordered the protective measure removed
despite that warning, and then allowed the resulting contaminated
product from Process 2 to reach the public.
When the predicted injuries appeared, Bourla escalated attempts to
silence the person who had warned the public and who was in Greece.
The single strongest piece of evidence would probably be the the
Pfizer logs , while the strongest overall case would be the
combination of those logs with independent evidence in the criminal
probes in Greece and Austria of crimes against a reporter for
warnings from 2009.
If the Pfizer manufacturing, quality control logs prove Bourla
repeatedly intervened to ensure standard safeguards were ignored and
warnings brushed aside, then his intention is proven. In fact, the
intention to release contaminated material to the public is proven by
the systematic sabotage of safeguards which are the pre requisite,
the sine qua non for Process 2.
That Bourla knew that the contaminated material could cause deaths
is shown by his familiarity with the reporters warnings which are
documented in 2009 and the criminal invesigation of Baxter for
similar contamination as confimed by the Austrian HealthMinister.
When the deaths and injuries did appear, and in the very specific
manner warned by the reporter, Bourla and his co conspirators did not
stop the material from being released. They instead undertook an
elaborate campaign of deception and intensified their suppression of
the reporter in the hope that the vital Baxter records and 2009
warnings would not reach the US AGs and their signifiance be
understood in showing that Borula intentionally contaminated the
Pfizer material and intentionally stood down existing safeguards to
prevent contamination at Pfizer facilities in the USA and elswhere
and to prevent investigators looking at Pfizer s internal records.
For the issue of Pfizer s criminal liability, I refer you to a
discussion on May 20 2026 between Lawyer Hans-Georg Maaßen and
Professor Sucharit Bhakdi called "The biggest organized crime
against humanity" ("Das größte organisierte Verbrechen
gegen die Menschheit")
https://www.youtube.com/watch?v=jhJrO8nVKks
Maassen and Bhakdi make several arguments that
overlap with German lawyers Ralf Ludwig's Process 2 criticism to the
Enquete-Kommission of Brandenburg Parliament on July 15th 2026,Paw
summarized in the Appendix, but they dsicuss toxicity and DNA
contamination and criminal liability of Pfizer and Bourla.
The key common thread is: the product that was actually administered
at scale allegedly differed from the product/process on which the
original regulatory and clinical evidence was based.
The main points they share
The clinical-trial product and mass-produced product were allegedly
made differently.
Bhakdi says the mRNA used for the first large clinical trial was
produced using a relatively “clean” manufacturing process, which
he calls Process 1. He then says the process was changed for the
billions of doses subsequently produced.
Process 2 was introduced for economic/scaling reasons.
Bhakdi claims the original process was too expensive for mass
production and that BioNTech therefore changed the manufacturing
process. Maassen then frames this as a potential contract/regulatory
compliance problem.
They argue that the change required regulatory approval/comparability
evidence.
This is the closest connection to Ludwig. Their argument is
essentially: if a regulator evaluated and authorized Product A, a
manufacturer cannot simply supply Product B without demonstrating
that B meets the relevant specifications and is covered by the
authorization.
They claim the necessary details of Process 2 were not adequately
disclosed.
Bhakdi says that the changed process was “never formally approved”
because, in his characterization, the relevant details were not
submitted. Maassen accepts this premise and develops the legal
consequences from it.
They distinguish the authorization from the product actually
delivered.
This is probably their strongest overlap with Ludwig. Maassen
explicitly summarizes the argument as: the states
purchased/authorized one product, while a differently manufactured
product was ultimately supplied.
They use a “specification/contract” analogy.
Maassen compares it to a government contracting a builder to
construct a bridge using specified materials. If the builder
substitutes cheaper material without authorization, the government's
duty is to inspect whether the delivered product still satisfies the
contract. His point is that the purchaser/regulator cannot simply
assume equivalence.
They argue that responsibility cannot simply be shifted between
authorities.
Maassen asks who was responsible for checking the changed product.
Bhakdi responds that the German authorities could not simply point to
the EMA. Their broader argument is that regulatory responsibility
remains with the relevant national/state institutions.
They connect the manufacturing change to bacterial-DNA contamination.
This is where their argument goes beyond the Process 2 point. Bhakdi
claims the new production process used bacterial DNA as a template
and that fragments remained in the final product. They characterize
this as a contamination problem resulting from mass production.
They argue that the allegedly contaminated product was therefore not
the same product that had been evaluated.
Maassen explicitly describes this as the decisive issue: a product
allegedly containing bacterial DNA was sold to governments even
though, in their account, the product originally tested/authorized
did not contain that contamination.
They argue that this could have both contractual and criminal
consequences.
Maassen's legal argument is that if governments ordered one product
but received another, the issue might not merely be “cancelling the
contract.” He suggests it could constitute non-performance/breach
of contract, potentially supporting claims for repayment, while the
alleged knowing distribution of a dangerous product could raise
criminal-law questions.
Where Maassen/Bhakdi go further than Ludwig
This distinction is important.
Ludwig's argument is primarily about the regulatory evidentiary
chain:
Process 2 differed → comparability had to be
demonstrated → specific data were required → Ludwig argues those
data were never properly supplied → therefore the authorization
cannot simply be assumed to cover the product actually administered.
Maassen and Bhakdi add a second layer:
Process 2 differed → it allegedly introduced
bacterial-DNA contamination → that contamination is allegedly
dangerous → therefore the mass-produced product was not merely
inadequately documented but potentially materially dangerous and
unauthorized.
And then they add a third layer:
If manufacturers and authorities knew or should have known this and
continued distribution, criminal liability could potentially arise.
One particularly revealing passage
Around 25:07–26:07, Maassen essentially combines all three
arguments. He says the product supplied to governments allegedly did
not correspond to what was purchased or licensed, and that if the
delivered product falls outside the authorization, the pharmaceutical
companies could potentially have civil and criminal liability.
That is very close to Ludwig's basic regulatory argument, but Maassen
makes the legal conclusion much more categorical.
To sum up
The continuing ongoing threat to my life by Bourla, Gates through
their intentional refusal to correct the violations in D 15 218 and E
17 449 to intentionally expose me to severe threats as a homeless and
penniless person is designed to suppress the evidence in my
possession from 2009 and to stop me conmunicating it to AGs in the
USA.
It consitutes witness tampring, obstruction of justice.
To prevent Bourla, Gates, Soros, Kushner , Trump and co conspirators
in the broad Epstein, Rothschild oligarchy who are the core group
behind covid, from continuing to threaten my life and destroy
evidence, I ask for their pretrial detention without bail and an
examination of whether the assets of Pfizer, the Foundations and
their busiensses should be frozen.
To this submission, I add summary of discssions by
German lawyer Ralf Ludwig on Process 2
APPENDIX 1
SUMMARY OF THE COMMENTS OF LAWYER RALF LUDWIG ON PROCESS 2
to the Enquete-Kommission des Landtags Brandenburg on July 15th 2026
https://www.youtube.com/watch?v=ZnJJm8cwTfM
Ludwig argues that the vaccine was allowed onto the market even
though the regulatory dossier was not yet complete. He says this
exceptional pathway should have triggered much greater caution.
Important data were still missing.
His central criticism is that regulators accepted gaps in the
evidence rather than waiting for all the usual information to become
available.
The pivotal clinical study was not yet fully finalized.
Ludwig points specifically to the fact that the final clinical study
report was not available when the initial conditional authorization
was granted.
There was limited evidence for certain population groups.
He highlights pregnant and breastfeeding women, immunocompromised
people, and other special groups as populations for which direct
evidence was limited or absent at the time.
Long-term effects could not yet be assessed.
Because the trials and follow-up period were necessarily short,
Ludwig argues that important longer-term safety questions remained
unresolved.
The duration of protection was not established.
He argues that the authorization did not yet answer how long
protection would last, making some subsequent claims about
vaccination more uncertain.
Transmission and protection of others had not been demonstrated.
Ludwig distinguishes protection of the vaccinated individual from
preventing transmission to other people. He argues that the latter
questions had not been conclusively answered at authorization.
Some evidence came from substitute/comparative data rather than
directly from the exact product.
He criticizes the use of different or substitute material in parts of
the evidence concerning distribution, breakdown and elimination in
the body, arguing that this weakened the evidentiary basis.
He alleges that established regulatory procedures were departed from.
This is actually one of his broader legal criticisms: emergency
conditions may explain why authorities acted quickly, but, in his
view, they do not justify abandoning established safety procedures or
checklists without a transparent justification.
The risk–benefit assessment therefore remained insufficiently
secure, in his view.
Ludwig's conclusion is that when significant data gaps and procedural
deviations exist, authorities and doctors cannot simply rely on the
fact that EMA or STIKO has approved/recommended the vaccine. They
must consider the unresolved risks themselves.
The core of his argument
Ludwig is essentially making a precautionary/legal-process argument:
A public-health emergency does not suspend the obligation to follow
safety procedures.
His airplane analogy captures it: if the warning indicators are
flashing, you don't simply say “it's an emergency, so we'll fly
anyway.” You investigate the warnings first. His 2026 testimony
explicitly frames the issue this way and argues that deviations from
established procedures should have been documented and justified.
PROCESS 2
Ludwig's criticism is
essentially that the product used in the pivotal Pfizer trial was not
manufactured by exactly the same process as the product that was
subsequently manufactured at commercial scale. The EMA documents
themselves confirm that Process 1 was used for the main
clinical-trial material, while Process 2 was developed for
large-scale production.
His argument can be broken down like this:
The clinical-trial product was Process 1.
Most of the vaccine used in Pfizer's pivotal trial came from the
original manufacturing process, called Process 1.
The mass-market product involved Process 2.
Pfizer developed Process 2 to manufacture the vaccine at much larger
scale. The manufacturing changes included differences in how the mRNA
was produced and purified.
Therefore, Ludwig says you cannot simply assume that the
clinical-trial evidence automatically applies to Process 2.
His legal/regulatory point is that a change in manufacturing process
can matter if it changes the characteristics of the finished product.
The whole purpose of pharmaceutical comparability testing is to
establish that the change has not materially altered the product.
There actually were measurable differences.
The EMA identified lower RNA integrity in the initial Process 2
batches compared with Process 1 and requested additional information.
This is why the EMA required additional comparability work.
The EMA did not simply ignore the difference. Pfizer modified Process
2, and the regulators subsequently concluded that the relevant
quality characteristics were sufficiently comparable.
Ludwig's criticism is that this creates a regulatory problem if
Process 2 wasn't adequately represented in the original clinical
evidence.
In other words: If the vaccine that demonstrated efficacy in the
pivotal trial was manufactured differently from the vaccine
subsequently supplied to millions of people, how strong is the
inference from the trial to the mass-produced product?
He particularly focuses on the timing.
An EMA peer-review document records that the first Process 2 doses
entered the trial in October 2020, but the interim analysis cut-off
occurred before those participants had received the relevant second
dose, meaning the interim efficacy analysis did not include Process 2
material.
He therefore treats this as a potentially serious departure from the
normal regulatory process, rather than merely a manufacturing
technicality.
The product used to establish the pivotal clinical evidence and the
commercially manufactured product were produced by materially
different processes; therefore the regulators needed to establish
comparability rigorously before treating the clinical evidence as
applicable to the mass-produced product.
The issue is not simply that “Process 2 was different.” The
regulatory question is whether the evidence necessary to establish
comparability was actually available at the time the initial
authorization was granted.
The EMA's own assessment report confirms several relevant facts:
The pivotal clinical material was predominantly produced using
Process 1.
Pfizer introduced Process 2 for scale-up.
EMA's comparability work found lower RNA integrity in the initial
Process 2 batches compared with Process 1.
EMA required additional information and Pfizer subsequently adjusted
Process 2.
The EMA ultimately considered the issue satisfactorily addressed.
But there is a crucial distinction concerning when the evidence was
available.
The trial protocol was amended so that approximately 250 participants
per Process 2 lot would receive Process 2 material, with
immunogenicity and safety compared against Process 1 recipients.
However, contemporary researchers pointed out that the results of
this Process 1/Process 2 comparison were not publicly available at
the time.
If Process 2 was materially different from the manufacturing process
used to generate the pivotal clinical evidence, then the regulator
needed corresponding comparability evidence before treating Process 2
as equivalent. His objection is that the necessary evidence was not
available in the dossier at the point at which the authorization
decision was made, yet Process 2 was nevertheless accepted.
Ludwig's claim is not merely that Process 2 was different. His claim
is that EMA required specific additional data to establish
comparability between Process 1 and Process 2, and that the required
data were never actually supplied in the form required. He therefore
disputes the premise that EMA had legitimately established
comparability.
That is a significant distinction because the EMA's own initial
assessment report contains language supporting part of the underlying
concern. It says that Process 1 was the clinical-trial process and
Process 2 the commercial process, and it explicitly states that
differences between the processes meant that “additional
characterisation data remain to be provided” as a specific
obligation. It also says that the available data did not permit a
definitive conclusion about some of the truncated RNA species and
expressed proteins.
So Ludwig's argument is essentially:
Process 1 generated the principal clinical-trial material.
Process 2 was a substantially changed manufacturing process intended
for commercial production.
Therefore, the regulatory authorities had to establish that the
Process-2 product was sufficiently comparable to the Process-1
product.
EMA itself identified missing data and imposed further data
requirements.
Ludwig argues that those requirements were not subsequently fulfilled
in the manner required.
Consequently, in his view, EMA could not legitimately treat the
Process-2 product as having the same evidentiary basis as the product
tested in the pivotal trial.
That potentially affects the legal validity of relying on the
clinical efficacy/safety evidence for the mass-produced vaccine.
And this is where I need to correct something from my previous
answer: saying simply that “EMA investigated Process 2 and
concluded it was comparable” skips over Ludwig's actual objection.
The question is what precise data EMA required, whether those data
were actually delivered, and whether the delivery satisfied the
specific obligation.
The EMA's public assessment does show that it identified outstanding
characterization work as a specific obligation (S01).
The fact that Comirnaty received conditional marketing authorization
on December 21, 2020 is also undisputed.